Business Description
Advaxis Inc
NAICS : 325414
SIC : 2834
ISIN : US0076242082
Description
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.28 | |||||
| 9-Day RSI | 45.55 | |||||
| 14-Day RSI | 46.62 | |||||
| 6-1 Month Momentum % | -27.97 | |||||
| 12-1 Month Momentum % | -76.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -7098.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.44 | |||||
| EV-to-EBITDA | 0.45 | |||||
| EV-to-Revenue | -41.65 | |||||
| Earnings Yield (Greenblatt) % | 227.27 | |||||
| FCF Yield % | -672.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ADXS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advaxis Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.254 | ||
| EPS (TTM) ($) | -9.93 | ||
| Beta | 0 | ||
| Volatility % | 122.17 | ||
| 14-Day RSI | 46.62 | ||
| 14-Day ATR ($) | 0.141357 | ||
| 20-Day SMA ($) | 1.071005 | ||
| 12-1 Month Momentum % | -76.32 | ||
| 52-Week Range ($) | 0.5 - 4.5 | ||
| Shares Outstanding (Mil) | 4.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advaxis Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advaxis Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Advaxis Inc Frequently Asked Questions
What is Advaxis Inc(ADXS)'s stock price today?
The current price of ADXS is $0.56. The 52 week high of ADXS is $4.50 and 52 week low is $0.50.
When is next earnings date of Advaxis Inc(ADXS)?
The next earnings date of Advaxis Inc(ADXS) is .
Does Advaxis Inc(ADXS) pay dividends? If so, how much?
Advaxis Inc(ADXS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers